By Helga Weires, Nerac Analyst
Originally published May 12, 2020
The world is facing unprecedented disruption due to the COVID-19 pandemic. Regardless of industry, companies are reacting quickly, placing an emphasis on safe operations and ramping up supply of essential ingredients and materials to address the crisis, while some are successfully pivoting into a completely new product line.
For many manufacturers and suppliers, this shift in the business landscape means looking at adjacent markets, new supply chain sources and embracing new ways of thinking and manufacturing processes that maximize chances of success, not just survival. How prepared are you to weather this storm?
This article explores our ability to “intelligently prepare” for innovation in times of crisis, and both the challenges and the opportunities that crises can present. Learn more here.
The article is free!
Simply fill in the form below, verify your email address
and you’ll be sent a link to download the article.
- 86By Helga Weires, Nerac Analyst, Originally Published: June 19, 2017 Some of the brightest novel products across industries are originating from existing – or old inventions. Innovation does not have to be born of a zero starting block. Developing new, brilliant products can be a function of taking existing tools and re-purposing them for an…
- 50New analyst brings experience in medical devices, neuroscience and biology. Read the full release here.
- 40By Donna Mitchell-Magaldi, Nerac Analyst, On March 20, 2010, the revised Guideline; MedDev 2.7.1 Rev 3 Clinical Evaluation: A Guide for Manufacturers and Notified Bodies became a requirement for obtaining and maintaining a CE Mark for all classes of devices marketed in the European Union. An important component of the MedDev 2.7.1 Rev 3 is the…